Bleichroeder LP - Mar 26, 2025 Form 4 Insider Report for LIQTECH INTERNATIONAL INC (LIQT)

Role: 10%+ Owner
Signature: Andrew Gundlach, Chairman and CEO of Bleichroeder LP
Stock symbol: LIQT
Transactions as of: Mar 26, 2025
Transactions value $: $0
Form type: 4
Date filed: 3/28/2025, 05:13 PM
Previous filing: Nov 19, 2024
Next filing: Apr 7, 2025
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LIQT	Warrants to Purchase Common Stock	Other		-531K	-100%		0	Mar 26, 2025	Common Stock	531K	$5.20	See footnote	F1, F2
transaction	LIQT	Warrants to Purchase Common Stock	Other		+531K			531K	Mar 26, 2025	Common Stock	531K	$2.00	See footnote	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On March 26, 2025, LiqTech International, Inc. and Bleichroeder LP, investment adviser to 21 April Fund, Ltd. and 21 April Fund, LP, agreed to amend (x) those certain 531,250 warrants to acquire Common Stock at an exercise price of $5.20 per share and having an expiration date of June 22, 2027 to (i) amend the exercise price to $2.00 per share and (ii) extend the expiration date to December 31, 2029.
F2	This form is filed by Bleichroeder LP. The securities reported herein are directly held by 21 April Fund, Ltd. and 21 April Fund, LP. Bleichroeder LP serves as registered investment adviser to 21 April Fund, Ltd., 21 April Fund, LP and other managed accounts. Bleichroeder LP disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that Bleichroeder LP is the beneficial owner of the securities for purposes of Section 16 or for any other purposes.

Content

On March 26, 2025, LiqTech International, Inc. and Bleichroeder LP, investment adviser to 21 April Fund, Ltd. and 21 April Fund, LP, agreed to amend (x) those certain 531,250 warrants to acquire Common Stock at an exercise price of $5.20 per share and having an expiration date of June 22, 2027 to (i) amend the exercise price to $2.00 per share and (ii) extend the expiration date to December 31, 2029.

This form is filed by Bleichroeder LP. The securities reported herein are directly held by 21 April Fund, Ltd. and 21 April Fund, LP. Bleichroeder LP serves as registered investment adviser to 21 April Fund, Ltd., 21 April Fund, LP and other managed accounts. Bleichroeder LP disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that Bleichroeder LP is the beneficial owner of the securities for purposes of Section 16 or for any other purposes.